Chemoinformaics analysis of 2-Phenylbenzimidazole
| Molecular Weight | 194.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 184.157 | nRig | 16 |
| Exact Molecular Weight | 194.084 | nRing | 3 |
| Solubility: LogS | -4.314 | nHRing | 1 |
| Solubility: LogP | 3.339 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 16 |
| nHA | 1 | APOL | 30.5779 |
| nHD | 1 | BPOL | 11.7421 |
| QED | 0.633 |
| Synth | 1.532 |
| Natural Product Likeliness | -1.057 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.024 |
| Pgp-sub | 0.055 |
| HIA | 0.004 |
| CACO-2 | -4.71 |
| MDCK | 0.0000286 |
| BBB | 0.868 |
| PPB | 0.975286 |
| VDSS | 1.08 |
| FU | 0.0277214 |
| CYP1A2-inh | 0.997 |
| CYP1A2-sub | 0.603 |
| CYP2c19-inh | 0.885 |
| CYP2c19-sub | 0.065 |
| CYP2c9-inh | 0.486 |
| CYP2c9-sub | 0.357 |
| CYP2d6-inh | 0.266 |
| CYP2d6-sub | 0.167 |
| CYP3a4-inh | 0.092 |
| CYP3a4-sub | 0.249 |
| CL | 6.113 |
| T12 | 0.719 |
| hERG | 0.042 |
| Ames | 0.821 |
| ROA | 0.103 |
| SkinSen | 0.096 |
| Carcinogencity | 0.669 |
| EI | 0.983 |
| Respiratory | 0.881 |
| NR-Aromatase | 0.235 |
| Antiviral | No |
| Prediction | 0.601513 |